Park Ha Biological Technology Co., Ltd.
PHH · NASDAQ
4/30/2025 | 10/31/2024 | 4/30/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Market Cap | $375 | $0 | $0 | $0 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $374 | -$0 | -$1 | -$1 |
| Revenue | – | – | – | – |
| % Growth | – | – | – | – |
| Gross Profit | – | – | – | – |
| % Margin | – | – | – | – |
| EBITDA | – | – | – | – |
| % Margin | – | – | – | – |
| Net Income | – | – | – | – |
| % Margin | – | – | – | – |
| EPS Diluted | – | – | – | – |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |